Abstract
This article compares and contrasts the PhRMA Methodological and Conduct Principles for Pharmacoeconomic Research and the pharmacoeconomic guidelines/principles from Australia, Great Britain, and Canada. Whereas the UK Guidance is the most general and the least prescriptive of the four sets of guidelines/ principles, the Canadian Guideline is the most detailed and prescriptive in nature. The PhRMA Principles consists of a set of broad principles that will foster high quality pharmacoeconomic research without impeding further methodological development of the field. The main focus of the PhRMA Principles is to rely on full disclosure and transparency of methods to permit knowledgeable readers to judge for themselves the adequacy of the methodological approach or to alter key parameters of the analyses to determine their impact. Copyright © 1995 by W.B. Saunders Company
Get full access to this article
View all access options for this article.
